FTVZX
Price
$33.53
Change
+$0.33 (+0.99%)
Updated
Jun 6 closing price
Net Assets
387.96M
MVCAX
Price
$30.34
Change
+$0.32 (+1.07%)
Updated
Jun 6 closing price
Net Assets
16.67B
Interact to see
Advertisement

FTVZX vs MVCAX

Header iconFTVZX vs MVCAX Comparison
Open Charts FTVZX vs MVCAXBanner chart's image
FullerThaler Behav Md-Cp Val R6
Price$33.53
Change+$0.33 (+0.99%)
VolumeN/A
Net Assets387.96M
MFS Mid Cap Value A
Price$30.34
Change+$0.32 (+1.07%)
VolumeN/A
Net Assets16.67B
FTVZX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTVZX vs. MVCAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTVZX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.7B vs. FTVZX (388M). FTVZX pays higher dividends than MVCAX: FTVZX (1.59) vs MVCAX (0.89). FTVZX was incepted earlier than MVCAX: FTVZX (7 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than FTVZX (0.87). FTVZX is a more actively managed with annual turnover of: 33.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than FTVZX: MVCAX (1000) vs FTVZX (1000000). FTVZX annual gain was more profitable for investors over the last year : 5.60 vs. MVCAX (-5.05). FTVZX return over 5 years is better than : 74.29 vs. MVCAX (40.08).
FTVZXMVCAXFTVZX / MVCAX
Total Expense Ratio0.750.9976%
Annual Report Gross Expense Ratio0.871.0087%
Fund Existence7 years24 years-
Gain YTD-2.295-2.151107%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets388M16.7B2%
Annual Yield % from dividends1.590.89177%
Returns for 1 year5.60-5.05-111%
Returns for 3 years10.730.851,258%
Returns for 5 years74.2940.08185%
Returns for 10 yearsN/A55.19-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMEFX40.68N/A
N/A
Nuveen Small/Mid Cap Growth Opp R6
MGEMX23.63N/A
N/A
Morgan Stanley Inst Emerging Mkts I
ATHWX20.31N/A
N/A
American Century Heritage R
BIOPX48.62N/A
N/A
Baron Opportunity Retail
FAPHX12.93N/A
N/A
Fidelity Healthy Future